Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: Low-level light therapy (LLLT) has been shown to modulate recovery in patients with traumatic brain injury (TBI). However, the longitudinal impact of LLLT on brain metabolites has not been studied. The purpose of this study was to use MR spectroscopic imaging to assess the metabolic response of LLLT in patients with moderate TBI at acute (within 1 week), subacute (2-3 weeks), and late-subacute (3 months) recovery phases. MATERIALS AND METHODS: This is a secondary analysis of a prospective single-site double-blind sham-controlled study conducted in patients with moderate TBI. Participants were randomized for LLLT and sham treatment. Three-Tesla 2D MR spectroscopic imaging was acquired. Our focus of investigation was the metabolic change in the corpus callosum (CC) and the changes in mIns/NAA, representing the combined effect of elevated neuroinflammation (mIns) and decreased neuronal/axonal health (NAA). A linear mixed-effects model was constructed to quantify the association between mIns/NAA and treatment, scan, and the interaction between treatment and scan. CONCLUSIONS: Despite the small sample size, MR spectroscopic imaging indicates a metabolic response in participants treated with LLLT compared with those receiving sham treatment. This potentially suggests a neuroprotective and anti-inflammatory effect from the acute administration of LLLT in individuals with moderate TBI.
No takes yet. Share an insight, caveat, or question.
Ratai et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: